Oppenheimer & Co’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261K Sell
76,284
-737
-1% -$2.48K ﹤0.01% 1450
2025
Q4
$218K Sell
77,021
-44,805
-37% -$231K ﹤0.01% 1400
2025
Q3
$848K Buy
121,826
+102,047
+516% +$719K 0.01% 972
2025
Q2
$117K Sell
19,779
-183,381
-90% -$1.05M ﹤0.01% 1551
2025
Q1
$1.3M Buy
203,160
+21,632
+12% +$209K 0.02% 691
2024
Q4
$2.16M Buy
181,528
+78,993
+77% +$1.35M 0.03% 521
2024
Q3
$2.84M Buy
102,535
+64,154
+167% +$1.61M 0.04% 434
2024
Q2
$915K Buy
38,381
+16,326
+74% +$383K 0.01% 806
2024
Q1
$388K Buy
+22,055
New +$325K 0.01% 1084

Other funds holding ASPN

Oppenheimer & Co's ASPN Position: Q1 2026 in Review

Oppenheimer & Co reduced its Aspen Aerogels (ASPN) stake by 0.96% in Q1 2026, selling an estimated $2.48K and leaving 76,284 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #1450.

Oppenheimer & Co first reported a position in ASPN in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.84M in Q3 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Oppenheimer & Co held 76,284 shares of Aspen Aerogels worth $261K as of Q1 2026.
  • Oppenheimer & Co sold 737 Aspen Aerogels shares in Q1 2026, an estimated $2.48K.
  • Aspen Aerogels made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1450 holding.
  • Oppenheimer & Co first reported a position in Aspen Aerogels in Q1 2024 and has held it in 9 quarters since.
  • Oppenheimer & Co's Aspen Aerogels position peaked at $2.84M in Q3 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.